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Edited by Barry HalliwellAbstract Animals spontaneously developing lupus-like autoim-
mune pathology (SLE) are very promising models to study the
mechanisms of natural abzymes (Abzs) generation and their role
in etiology and pathogenesis of autoimmune diseases, but Abzs
from the sera of animals remain virtually unstudied. In this work,
electrophoretically homogeneous IgGs were isolated from the
sera of MRL/MpJ-lpr mice. It was shown for the ﬁrst time that
amylase activity is an intrinsic property of antibodies (Abs) and
their isolated heavy and light chains. Various markers of SLE
pathology (proteinuria, enhanced concentration of anti-DNA
Abs) increased with spontaneous development of SLE and espe-
cially after animal immunization, correlating with the increase in
Abz relative amylase activity. The highest amylase activity was
found in the sera Abs of healthy mice after delivery and at the
beginning of lactation; this was not correlated with markers of
mouse SLE but supports the idea that pregnancy could ‘‘acti-
vate’’ or ‘‘trigger’’ autoimmune-like manifestations and Abzs
production in healthy mammals. The possible diﬀerences in
mechanisms of Abzs production in lactating mice and animals
developing SLE are discussed.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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hydrolysis1. Introduction
Catalytic Abs against transition states of chemical reactions
(artiﬁcial Abzs) and natural Abzs are novel biological catalysts
that attracted much interest in the recent years and have been
amply reviewed recently [1–5]. Natural Abzs hydrolyzing
DNA, RNA, polysaccharides, oligopeptides, and proteins are
described in the sera of patients with several AI and viral dis-
eases (reviewed in [1–5]). Abzs can be produced not only in the
organisms of AI patients, but healthy humans usually eitherAbbreviations: Abs, antibodies; Abzs, abzymes or catalytically active
antibodies; AI, autoimmune; SLE, systemic lupus erythematosus;
SDS–PAGE, SDS–polyacrylamide gel electrophoresis; MHO, malto-
heptaose; RAA, relative amylase activity
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doi:10.1016/j.febslet.2006.08.036lack Abzs, or their proteolytic and nuclease activities are on
a borderline of the sensitivity of detection methods [2–12].
Nuclease Abzs were not revealed in the sera of healthy volun-
teers or patients with many diseases with insigniﬁcant AI reac-
tions [13,14]. Patients with diﬀerent AI diseases demonstrated
5–160-fold higher amylase activity than healthy volunteers
[5,11,12,15,16]. Monoclonal mouse Abs with amylase activity
were generated using the approach of Ab induction to a
half-chair transition-state analog [17].
Diﬀerent Abzs present a convenient diagnostic marker of AI
pathologies development; increased Abz activities are among
the earliest and clear signs of AI reactions in a number of AI
and viral diseases (SLE, Hashimoto’s thyroiditis, polyarthritis,
multiple sclerosis, AIDS, hepatitis) [2–5]. In addition, Abzs
play an important role in pathogenesis of AI diseases (for re-
view see [2–5]).
During pregnancy and especially after the beginning of lac-
tation, women are often characterized by immune processes
similar to those for AI patients ([5,18] and Refs. therein). sIgA
and/or IgG possessing DNase and RNase, ATPase, amylase,
or protein, lipid, and polysaccharide kinase activities were re-
vealed in the milk, and some of them, in the sera of lactating
mothers [2–5,18]. DNase, RNase, ATPase, and amylase activ-
ities of milk Abs were signiﬁcantly higher than those of IgGs
from the sera of lactating women [2–5,12,18,19].
Human SLE is characterized by maximal level of anti-DNA
Abs and Abzs with nuclease and amylase activities [2–
5,12,18,19] and represents a very promising model to study
the mechanisms of natural Abzs generation and their role in
etiology and pathogenesis of severe AI disturbances. Many
questions concerning SLE Abzs can be answered only using
experimental animals for modeling certain states of immune
system, but animal models have not yet been widely used for
study of the mechanisms of Abzs accumulation.
A convenient and widely accepted SLE model is MRL/MpJ-
lpr mice, which spontaneously develop marked hypergamma-
globulinemia, production of numerous auto-Abs, circulating
immune complex, glomerulonephritis and severe lymphade-
nopathy [20]. A mutation in the lpr gene of these mice leads
to homozygotes having a deﬁcit in functional Fas ligand and
dysregulation of apoptosis [21]. As a result, the mice develop
the SLE-like phenotype. Recently, it was shown that, similar
to SLE patients, the sera of MRL/MpJ-lpr mice contain
DNAse IgGs [22]. Here, we present the ﬁrst evidence that poly-
clonal IgGs from the sera of MRL/MpJ-lpr mice possessblished by Elsevier B.V. All rights reserved.
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SLE (proteinuria, titers of Ab to native DNA) during various
stages of SLE, pregnancy and lactation was analyzed.Fig. 1. Analysis of IgG homogeneity by SDS–PAGE in a non-
reducing 4–15% gradient gel (lane 1) and in a reducing 12% gel (lane 2)
followed by silver staining of IgG (Abs after gel-ﬁltration). Arrows
indicate the positions of molecular mass markers (lane 3).2. Materials and methods
Most chemicals, proteins, and Protein A-Sepharose were from
Sigma or Pharmacia. Control non-AI BALB/c or (CBA · C57BL)F1
and AI-prone MRL/Mpj-lpr mice were housed in the colonies under
approved standard conditions at the SD RAS ICG mouse breeding
facility.
Mice were immunized three times with 40 lg of DNA per mouse
using a conjugate of calf thymus DNA with methylated BSA as in
[22]. The blood of the mice was used for the Abs analysis one month
after the ﬁrst immunization. The proteinuria and ELISA analysis of
anti-DNA Abs were conducted as in [22]. The serum concentrations
of anti-DNA Abs was expressed as a diﬀerence in the relative absor-
bance at 450 nm (A450) of experimental and control samples. Electro-
phoretically homogeneous mouse IgGs were obtained by sequential
aﬃnity chromatography of the serum proteins on protein A-Sepharose
and FPLC gel ﬁltration in the 0.1 M glycine–HCl (pH 2.6) on a Super-
dex 200 HR 10/30 column [18,22]. Chromatography of puriﬁed IgGs
on Sepharose bearing rabbit IgGs against mouse IgGs was performed
similarly to the chromatography on Protein A-Sepharose [22]. The ab-
sence of IgAs and IgMs impurities in the IgG fractions was shown
using the Ouchterlony double immunodiﬀusion method against anti-
IgA and anti-IgM Abs and by Western blotting on a nitrocellulose
membrane as described previously [24].
The reaction mixture (20 ll) containing 50 mM Tris–HCl, pH 7.5,
1 mM NaN3, 1.5 mM MHO and 0.001–0.2 mg/ml of IgGs was incu-
bated for 12 h at 30 C. Products of hydrolysis were identiﬁed by
TLC on Kieselgel F254 plates (Merck) using 1-butanol–acetic acid–
H2O (12:4:4) [15,16,19]. The activities of IgGs were determined from
the scanning data as a percentage of oligosaccharide in spots of
MHO and its hydrolyzed forms. All measurements were taken within
the linear regions of the time courses and Ab concentration curves. In
the case of low Ab activities (<5–10% of hydrolysis), the incubation
time was increased to 18–24 h. If the MHO hydrolysis during 12 h of
incubation was more than 40%, the concentration of Abs was de-
creased 2–100-fold depending on the sample analyzed. Finally, the
RAAs were recalculated to the standard conditions: 0.1 mg/ml IgGs
and 12 h of incubation. The KM and Vmax (kcat) values were calculated
from the kinetic data by least-squares non-linear ﬁtting using Microcal
Origin v5.0 software and presented using diﬀerent transformations
[23].
SDS–PAGE analysis of Abs for homogeneity under non-reducing
conditions was done in 4–15% gradient gels; for polypeptide separation
it was performed in a reducing 12.5% gel (0.1% SDS and 10 mM DTT)
and the polypeptides were visualized by silver staining [14–16,22]. For
SDS–PAGE assay of amylase activity, IgGs (7–10 lg) were preincu-
bated at 30 C for 30 min under non-reducing (buﬀer A: 50 mM
Tris–HCl, pH 7.5, 1% SDS, and 10% glycerol), or mild reducing con-
ditions (buﬀer A + 5% 2-mercaptoethanol) [24]. To restore the activity,
SDS was removed by incubating the gel for 1 h at 22 C with K-phos-
phate (pH 6.8) and the gel was washed ﬁve times with water. Then 3–4-
mm cross-sections of longitudinal slices of the gel were cut out and
incubated with 50 ll of 20 mM Tris–HCl, pH 7.5, 5 mM MgCl2 and
1 mM EDTA for two days at 4 C to allow protein refolding and elut-
ing from the gel. The solutions were removed from the gels by centri-
fugation and used for the activity assay as described above. Parallel
longitudinal gel slices were used for detecting the position of IgG in
the gel by Coomassie R250 staining.Fig. 2. Amylase activity of puriﬁed IgG by TLC on Kieselgel F254:
lanes 1–9 correspond to the 12 h incubation of 1.5 mM MHO in the
presence of 0.1 mg/ml IgGs from 9 diﬀerent AI-prone MRL/MpJ-lpr
mice; lane 10, with IgGs from a BALB/c mouse; lane 11 MHO
incubated alone.3. Results and discussion
The total Ig fractions (IgG + IgM + IgA) were puriﬁed from
the sera of individual mice by chromatography on Protein A-
Sepharose under special conditions to remove non-speciﬁcally
bound proteins [13,17–19]. Then IgGs were separated from
IgA and IgM fractions by FPLC gel ﬁltration in an acidic buf-fer (pH 2.6) dissociating strong non-covalent protein com-
plexes. The homogeneity of the typical 150-kDa IgG was
conﬁrmed by SDS–PAGE with silver staining, which showed
a single band under non-reducing conditions and two bands
corresponding to the H and L chains after Ab reduction
(Fig. 1). After all stages of puriﬁcation, IgG samples of most
mice, which were ill, demonstrated detectable or high amylase
activity (Fig. 2).
We applied a set of strict criteria worked out previously [2–6]
for an analysis of amylase activity as an intrinsic property of
MRL/MpJ-lpr mouse IgGs. The most important of these are:
(i) electrophoretic homogeneity of IgGs (Fig. 1); (ii) complete
absorption of the amylase activity by Sepharose bearing rabbit
Abs against mouse IgGs, leading to a disappearance of the
activity from the solution, and its elution with an acidic buﬀer
(pH 2.6; Fig. 3A); (iii) FPLC gel ﬁltration of IgGs using an
acidic buﬀer (pH 2.6) did not lead to a disappearance of the
activity, and the peak of the amylase activity tracked exactly
with IgGs (Fig. 3B).
To exclude possible artefacts due to hypothetical traces of
contaminating enzymes, the IgG was separated by SDS–
PAGE and its amylase activity was detected after extraction
of proteins from the excised gel slices (Fig. 4A). Before reduc-
tion, the activity was revealed only in the band corresponding
to intact IgGs. After complete reduction of IgG by boiling, the
SDS–PAGE assay showed no activity in the intact IgG and in
its separated L or H-chains. After mild treatment of IgG with
5% 2-mercaptoethanol followed by reducing SDS–PAGE, the
amylase activity was revealed in the bands corresponding to
the intact IgG (H2L2) and its partially reduced forms (H2L,
Fig. 3. Application of strict criteria to prove that amylase activity of
IgGs is an intrinsic property of polyclonal mouse Abs: (A) aﬃnity
chromatography of IgG on Sepharose bearing rabbit IgGs against
mouse IgGs: (–), absorbance at 280 nm, the relative amylase activity
(RAA) of IgGs (s); (B) FPLC gel ﬁltration of IgGs on a Superdex 200
column in an acidic buﬀer (pH 2.6) after Abs incubation with this
buﬀer: (–), absorbance at 280 nm; the RAA of IgGs (h). The RAAs of
the fractions with the highest activities were taken as 100%.
Fig. 4. (A) SDS–PAGE analysis of amylase activity of intact IgG and
its separated light and heavy chains. Before electrophoresis, the IgG
samples (10 lg per sample) were incubated under non-reducing (s)
or mild (5% 2-mercaptoethanol) reducing conditions (j). After
electrophoresis, the gels were incubated under special conditions for
protein refolding (see Section 2). Then the relative amylase activity
(RAA) was analyzed using extracts of 2–3 mm fragments of longitu-
dinal slices of the gel (s and j). In each experiment the second
longitudinal slice of the same gel was silver-stained: (B) (—) under non-
reducing and (C) (- -) under reducing conditions. Arrows indicate the
positions of intact IgG, and its separated L and H chains.
A.A. Andryushkova et al. / FEBS Letters 580 (2006) 5089–5095 5091HL2, and HL) as well as in the separated H and L chains
(Fig. 4B).
Interestingly, catalytic centers of Abzs hydrolyzing proteins,
DNA, and RNA are most often located in the variable part of
light chains of Abs [2–5]. From the crystal structure of a cata-
lytic Ab with an esterase-like activity, p-nitrophenyl ester inter-
acts with amino acid residues in both light and heavy chains of
Abzs, and both types of subunits are required for catalysis [25].
The DNAse center of human milk sIgAs is located in the light
chain, while the DNA-binding center is mainly formed by the
heavy chain [26]. The active site of milk IgGs ATPase is
formed by both light and heavy chains of the Abzs at their
interface, and the separated subunits are not catalytically ac-
tive [24]. The DNAse center of monoclonal IgGs from AI-
prone MRL-lpr/lpr mice is located at the interface between
the light and heavy chains, and the separated chains are able
to hydrolyze DNA [27]. The above data strongly suggest thatamylase activity is an intrinsic property of diﬀerent oligomeric
forms and separated L- and H-subunits of mouse IgG. Taking
into account the polyclonality of mouse IgGs, one cannot ex-
clude that Ab amylase centers may exist only in the light or in
the heavy chains of speciﬁc subfractions of Abzs, formed by
both chains, or it may be a ‘‘cocktail’’ of Abs with all types
of monoclonal Abzs organization.
The level of amylase activity varied extensively from mouse
to mouse. To compare the RAAs of all IgGs they were recal-
culated to standard conditions (0.1 mg/ml Abs, 12 h incuba-
tion) and a complete hydrolysis of MHO was taken as 100%
activity. First, we have compared the Abz RAAs of healthy
AI-prone 2–3-months-old MRL/MpJ-lpr and of non-AI con-
trol BALB/c and (CBA · C57BL)F1 mice of various ages (3–
7 months, Table 1). The control non-AI mice at 3–7 months
of age and 2–3-months-old AI-prone MRL/MpJ-lpr mice dem-
onstrated no proteinuria (0.1–0.38 mg/ml> 3 mg/ml), very
low concentrations of anti-DNA Abs (0.03–0.08 A450), and
the absence or very low amylase activities, 1–1.9% on average
(Table 1).
MRL/MpJ-lpr males and females of 7 months of age with
visual symptoms of spontaneous AI pathology were charac-
terized by high proteinuria (5–8.0 mg/ml), 2–5.6 times
higher anti-DNA Ab concentrations (0.18–0.16 A450) and
Table 1
Autoimmune characteristics of autoimmune-prone MRL/MpJ-lpr and control non-autoimmune mice
Animal groups Number
of mice
Proteinuria
(mg/ml)a
Abs to native
DNA A450
Range of
RAAs (%)c
Average values
of RAAs (%)
Control non-autoimmune males (4 mice) and females (4 mice)
(CBA · C57BL) F1 (3–7 months) 8 0.12 ± 0.07b 0.04 ± 0.01b 0–2.3 1.0 ± 0.5
Balb/c (3–7 months) 8 0.1 ± 0.08 0.03 ± 0.01 0–2.1 1.1 ± 0.5
Groups of MRL/MpJ-lpr males
Healthy MRL/lpr (2–3 months) 5 0.38 ± 0.02 0.032 ± 0.01 0–4.3 1.9 ± 1.2
Ill MRL/lpr (7 months) 5 8.0 ± 3.1 0.18 ± 0.08 2.0–5.6 3.7 ± 1.0
Healthy MRL/lpr, Immunized (2–3 months) 5 9.5 ± 1.7 0.6 ± 0.17 5.0–28.0 17.6 ± 7.5
Groups of MRL/MpJ-lpr females
Healthy MRL/lpr (2–3 months) 5 0.31 ± 0.3 0.08 ± 0.03 0–4.1 1.8 ± 1.1
Ill MRL/lpr (7 months) 5 5.0 ± 3.8 0.16 ± 0.12 3.2–18.3 9.2 ± 5.4
Healthy pregnant MRL/lpr (2–3 months) 5 0.31 ± 0.2 0.24 ± 0.05 0.3–9.8 3.9 ± 3.6
Healthy lactating MRL/lpr, 5 days after delivery (2–3 months) 5 0.32 ± 0.1 0.54 ± 0.3 6.7–100 31.7 ± 27.3
Healthy lactating MRL/lpr, 2 weeks after delivery (2–3 months) 5 0.70 ± 0.3 0.57 ± 0.28 2.8–28.4 13.7 ± 11.0
aProteinuria corresponds to P 3 mg of total protein/ml of urine.
bFor each mouse, a mean of three repeats is used.
c100% of RAA corresponds to a complete hydrolysis of maltohexaose (1.5 mM) in the presence of 0.1 mg/ml IgGs at 30 C for 12 h, extremes of the
range for each group of mice are given.
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of healthy 2–3-months-old MRL/MpJ-lpr males with DNA led
to a fast development of proteinuria (9.5 mg/ml), very high
level of anti-DNA Abs (0.6 A450) and a 9.3–17.6-fold in-
crease in the RAA (17.6%) as compared with healthy mice
(Table 1).
Clinically, healthy pregnant women may be eﬀectively
immunized by components of various viruses and bacteria
and autoimmunization of mothers during pregnancy similar
to that in AI patients may occur ([2–5,18] and Refs. therein).
A sharp exacerbation of AI reactions can occur in some cases
soon after childbirth and postnatal AI pathologies arise some-
times, including SLE, Hashimoto’s thyroiditis, phospholipids
syndrome, polymyositis, AI myocarditis, etc. [28,29]. Thus,
one cannot exclude that molecular mechanisms of immune sys-
tem activation leading to production of autoreactive Abs and/
or auto-Abs are, to some extent, similar or overlapping in both
AI patients and human mothers.
In contrast to mice with spontaneous SLE and immunized
males (5–9.5 mg/ml), signiﬁcant proteinuria was not detected
in females during pregnancy (0.31 mg/ml), 5 days (0.32 mg/
ml), or 2 weeks (0.7 mg/ml) after delivery and the beginning
of lactation (Table 1). The concentrations of anti-DNA Abs
(0.24 A450) in pregnant animals were 3–8 times higher than
in healthy 2–3-months-old mice (0.03–0.08 A450) and slightly
higher than in ill mice of 7 months of age (0.16–0.18 A450).
Interestingly, 5 days and 2 weeks after the beginning of lacta-
tion the concentration of anti-DNA Abs was increased 2.4-
fold (0.54–0.57 A450) in comparison with that in pregnant mice
and became comparable with that in immunized males (0.6
A450). Thus, the high level of anti-DNA Abs for pregnant
and lactating mice does not correlate with the proteinuria
index (Table 1).
After the beginning of lactation, the RAA increased sharply
3.5–8-fold to 31.7% on average and then after 2 weeks of lac-
tation decreased to 13.7% (Table 1), similarly to a 5–10-fold
increase in DNase and ATPase Abz activities in lactating
mothers in comparison with pregnant women [18,24]. The
RAA of IgGs varied widely between mice, but only immunized
and lactating mice demonstrated Abzs with very high, 28–100%, activities (Table 1). Typical estimates of the apparent
KM and kcat values for MHO are given in Fig. 5. The data ob-
tained are summarized in Table 2. IgGs with low RAA from
both healthy and ill males, or from pregnant females demon-
strated only a single KM and kcat value (Table 2). These sam-
ples of the antibody-mediated amylase activity at varying
concentrations of substrate were consistent with simple
Michaelis–Menten kinetics, while another IgGs demonstrated
more complicated curves corresponding to a sum of two or
three hyperbolic curves of Abs saturation with substrate. IgGs
of two immunized males with low and high RAAs demon-
strated three diﬀerent KM values, and all three kcat values for
the second Ab were 2.4–22-fold higher than those for the ﬁrst
one (Table 2). IgG with low RAA from one lactating female
showed two KM and two kcat values, while the Ab from an-
other lactating female with high RAA demonstrated three
KM values and signiﬁcantly higher kcat values (Table 2). Thus,
the increase in Abz RAA in mice can be due to an increase in
the relative amount of one type of monoclonal Abs in the poly-
clonal Ab pool, or to a broadening of the monoclonal Abzs
repertoire.
The catalysis mediated by artiﬁcial Abzs is usually character-
ized by 102–106-fold lower kcat values than those for canonical
enzymes [1–5]. The known kcat values for natural Abzs from
AI patients varied in the range 0.01–15.6 min1 [2–6,9,24,30–
32]. Thus, the speciﬁc amylase activities of polyclonal mouse
IgGs (Table 2) are comparable or even signiﬁcantly higher
than those for some artiﬁcial and natural Abzs. In addition,
the KM and kcat values for MHO (Table 2) are comparable
with those for Abzs from the sera of AI-patients and human
milk (KM = 0.13–7.0 · 104 M and kcat = 0.05–19.4 min1)
[15,16,19]. Mouse Abzs possess 5–10-fold higher aﬃnity for
MHO, but 102-fold lower speciﬁc activity in comparison with
canonical mammalian a-amylases [11,12,15,16]. However, it is
not surprising, since the pool of polyclonal Abs usually con-
tains only <1–5% Abzs with amylase or any other Abz activi-
ties [2–5].
The increase in RAA in MRL/MpJ-lpr mice is correlated
with a development of a spontaneous SLE pathology, high lev-
els of proteinuria, and anti-DNA Abs (Table 1). Pregnant and
Fig. 5. Determination of the KM and Vmax values for maltohexaose in the reaction catalyzed by IgG preparations from two mice (A and B) using the
Cornish–Bowden plot. In the insets of each ﬁgure, the same data are presented using V vs S plots. The reactions were performed as described in
Section 2.
Table 2
The KM and kcat values characterizing the hydrolysis of maltohexaose by IgGs from the sera of diﬀerent autoimmune-prone MRL/MpJ-lpr mice
a
IgG from the sera of diﬀerent mice KM(1) (mM)
b kcat(1) (min
1)b KM(2) (mM) kcat(2) (min
1) KM(3) (mM) kcat(3) (min
1)
Healthy male (3 months) 6.1 ± 0.3 0.1 ± 0.02 Not exist Not exist Not exist Not exist
Ill male (7 months) 2.0 ± 0.25 0.19 ± 0.04 Not exist Not exist Not exist Not exist
Immunized male (3 months) 0.5 ± 0.1 0.1 ± 0.02 0.9 ± 0.1 0.15 ± 0.03 7.2 ± 0.2 0.69 ± 0.15
Immunized male (3 months) 0.6 ± 0.15 1.0 ± 0.15 2.2 ± 0.3 5.0 ± 1.0 6.4 ± 1.5 15 ± 0.15
Pregnant female (3 months) 6.4 ± 1.0 0.9 ± 0.15 Not exist Not exist Not exist Not exist
Lactating female (5 days after delivery) 1.0 ± 0.2 0.15 ± 0.04 6.7 ± 1.0 1.3 ± 0.2 Not exist Not exist
Lactating female (5 days after delivery) 1.2 ± 0.18 1.6 ± 0.17 2.4 ± 0.4 6.0 ± 1.5 6.8 ± 1.7 11 ± 0.15
aFrom 1 to 3 KM values were determined depending on the IgG preparation.
bMeans ± S.D. of three measurements are given.
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oping the increased levels of anti-DNA Abs, Abzs with amy-
lase (Table 1) or DNAse [22] activities without proteinuria.
Our ﬁndings are in agreement with a temporary character ofAI-reactions and increased levels of Abzs in pregnant and lac-
tating women and mice, while SLE pathology in mammals is
characterized by lasting increased proteinuria, anti-DNA
Abs, Abz activities and enhancement of these indexes during
5094 A.A. Andryushkova et al. / FEBS Letters 580 (2006) 5089–5095exacerbation of AI pathologies [2–5,18]. Thus, an appearance
of DNAse [18] and a signiﬁcant increase in amylase activity
of non-pregnant MRL/MpJ-lpr mice can be considered a pro-
found indicator of SLE pathology development.
Human and animal milk contains IgG, IgM, IgA, and sIgA,
of which sIgA is the major component (>85–90%) [33]. The
‘‘immuno-memory’’ of pregnant females ‘‘collects informa-
tion’’ about all inside and outside compounds and after the
beginning of lactation mammals produce serum and milk
Abs, including Abzs, against these compounds [2–5,18,24].
Possible mechanisms of Abzs production in lactating and ill
mammals may partially overlap. After the beginning of lacta-
tion the bulk of women Abz activities belong to milk IgGs and
especially to sIgAs, while the speciﬁc activities of the serum
Abzs are signiﬁcantly lower [2–5,18,24]. sIgA is selectively pro-
duced by plasma cells residing in the interstitial tissue under-
lying the epithelial surfaces of the lactating breast [34]. These
lymphoid cells migrate to the breast from the maternal intesti-
nal lymphoid tissues (Peyer’s patches) and from lymphoid cen-
ters in the bronchial tree [34,35]. The germinal-center B cells of
Peyer’s patches express mainly surface IgA along with some
IgM or IgG [35]. Such isotype skewing is the result of B-cell
heavy-chain gene switching in the course of clonal diﬀerentia-
tion to the precursors of IgA-producing immunocytes, whose
preferential induction is the hallmark of gut-associated lym-
phoid tissue [36]. Milk IgGs may be synthesized locally by such
lymphoid tissue and also originate, at least partially, from the
mother’s circulation [37]. The serum Abs of AI-patients are
produced mainly by B-lymphocytes of diﬀerent organs. A
perpetually growing number of observations suggest that AI
diseases originate from defects in diﬀerentiation and prolifera-
tion of hematopoietic stem cells [38]. It is clear that there may
be a signiﬁcant diﬀerence in the mechanisms of Abzs produc-
tion and the biological roles of Abzs in lactating females and
in patients with AI pathologies. After the beginning of lacta-
tion the ‘‘immuno-memory’’ of females can be speciﬁcally
switched to activation of immunocytes in Peyer’s patches
and lymphoid tissue producing milk Abs, and the increase in
Abzs activities in the serum may be in some extent a side eﬀect.
In contrast to AI diseases, all these Abs usually disappeared
after end of lactation [2–5]. One cannot exclude that the
changes in diﬀerentiation and proliferation in hematopoietic
stem cells of some tissues and organs occurring in AI patients
cannot be easy returned to the norm, while an easy silencing of
the ‘‘immune memory’’ in lactating women is a programmed
phenomenon. Taking into account our data and the literature
reports (for review see [2–5]) we have proposed recently that
catalytic Abzs of mother’s milk may have a protective function
during breast-feeding of the newborn. The study of the biolog-
ical functions of milk Abs is in progress.
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